Access cutting-edge heart attack treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access heart attack specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart attack treatment provided free
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. The participant w
Sponsor: Novo Nordisk A/S
Check if you qualify for this heart attack clinical trial in Phoenix, AZ
If you're searching for heart attack treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart attack specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.